Long-term disease control by trabectedin in a patient with dedifferentiated liposarcoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-term disease control by trabectedin in a patient with dedifferentiated liposarcoma

Published:2020-01 Issue:2 Volume:99 Page:e18689
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Matsuda Shogo,Tanaka Kazuhiro,Kawano Masanori,Iwasaki Tatsuya,Itonaga Ichiro,Tsumura Hiroshi

Funder

National Cancer Center Research and Development Fund

AMED

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference9 articles.

1. Trabectedin in metastatic soft tissue sarcomas: role of pretreatment and age;Hoiczy;Int J Oncol,2013

2. Efficacy and safety of trabectedin or dacarbazine for metastatic liposarcoma or leiomyosarcoma after failure of conventional chemotherapy: results of a phase III randomized multicenter clinical trial;Demetri;J Clin Oncol Mar,2016

3. Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomized, open-label, phase 2 study;Kawai;Lancet Oncol,2015

4. Randomized phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas;Blay;Eur J Cancer,2014

5. Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study;Grosso;Lancet Oncol,2007

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrophage-Based Therapeutic Strategies in Hematologic Malignancies;Cancers;2023-07-22

2. Clinical characteristics of sarcoma cases in which long-term disease control was achieved with trabectedin treatment: A retrospective study;PLOS ONE;2023-03-01

3. The Role of Macrophages in Cancer Development and Therapy;Cancers;2021-04-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3